CHARM Therapeutics
Uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Launch date
Employees
Market cap
-
Enterprise valuation
€73—109m (Dealroom.co estimates Apr 2023.)
Company register number 13641471
London England (HQ)
Authorizing premium user...